TCIM
AGN

TIAA CREF Investment Management’s Allergan plc AGN Stock Holding History

TIAA CREF Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$291M Sell
1,990,249
-528,642
-21% -$76.6M 0.21% 100
2018
Q4 		$337M Sell
2,518,891
-781,352
-24% -$128M 0.27% 74
2018
Q3 		$629M Sell
3,300,243
-80,842
-2% -$14.9M 0.41% 49
2018
Q2 		$564M Buy
3,381,085
+130,258
+4% +$20.9M 0.38% 56
2018
Q1 		$547M Buy
3,250,827
+1,859,697
+134% +$312M 0.37% 60
2017
Q4 		$228M Sell
1,391,130
-1,359,521
-49% -$244M 0.15% 138
2017
Q3 		$564M Sell
2,750,651
-276,057
-9% -$64.2M 0.38% 57
2017
Q2 		$736M Sell
3,026,708
-137,729
-4% -$32.4M 0.52% 36
2017
Q1 		$756M Sell
3,164,437
-310,501
-9% -$72.3M 0.54% 32
2016
Q4 		$730M Sell
3,474,938
-407,798
-11% -$84.5M 0.54% 32
2016
Q3 		$894K Sell
3,882,736
-98,141
-2% -$24M 0.56% 34
2016
Q2 		$920M Sell
3,980,877
-247,742
-6% -$57.1M 0.71% 24
2016
Q1 		$1.13B Buy
4,228,619
+437,912
+12% +$125M 0.87% 15
2015
Q4 		$1.18B Buy
3,790,707
+107,189
+3% +$31.9M 0.89% 15
2015
Q3 		$1B Sell
3,683,518
-110,541
-3% -$34M 0.79% 18
2015
Q2 		$1.15B Sell
3,794,059
-131,673
-3% -$39.3M 0.82% 15
2015
Q1 		$1.17B Buy
3,925,732
+1,393,972
+55% +$397M 0.81% 15
2014
Q4 		$652M Buy
2,531,760
+427,085
+20% +$107M 0.46% 41
2014
Q3 		$508M Buy
2,104,675
+397,415
+23% +$88.9M 0.36% 54
2014
Q2 		$381M Sell
1,707,260
-75,151
-4% -$15.6M 0.27% 77
2014
Q1 		$367M Buy
1,782,411
+52,799
+3% +$10.5M 0.26% 79
2013
Q4 		$291M Buy
1,729,612
+251,921
+17% +$39.4M 0.21% 99
2013
Q3 		$213M Sell
1,477,691
-161,813
-10% -$21.6M 0.17% 132
2013
Q2 		$207M Buy
+1,639,504
New +$186M 0.17% 126

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TIAA CREF Investment Management's AGN Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Allergan plc (AGN) stake by 21% in Q1 2019, selling an estimated $76.6M and leaving 1,990,249 shares worth $291M. The position accounts for 0.21% of the portfolio, ranked #100.

TIAA CREF Investment Management first reported a position in AGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.18B in Q4 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • TIAA CREF Investment Management held 1,990,249 shares of Allergan plc worth $291M as of Q1 2019.
  • TIAA CREF Investment Management sold 528,642 Allergan plc shares in Q1 2019, an estimated $76.6M.
  • Allergan plc made up 0.21% of TIAA CREF Investment Management's portfolio in Q1 2019, its #100 holding.
  • TIAA CREF Investment Management first reported a position in Allergan plc in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Allergan plc position peaked at $1.18B in Q4 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.